SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-21-024169
Filing Date
2021-02-16
Accepted
2021-02-16 16:33:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm216840d13_sc13ga.htm SC 13G/A 60106
  Complete submission text file 0001104659-21-024169.txt   61652
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Subject) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88909 | Film No.: 21639386
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

IRS No.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A